Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
The sensitivity of ELISA assays for dopamine and noradrenaline ... that is the synthesis of specific DNA conjugates from any binding protein of the customer's interest. Moreover, to provide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback